Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 14 | 2023 | 2282 | 2.500 |
Why?
|
Iodine Radioisotopes | 5 | 2021 | 1032 | 1.900 |
Why?
|
Carcinoma, Papillary | 3 | 2023 | 783 | 1.060 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2021 | 324 | 0.970 |
Why?
|
Mitotane | 1 | 2019 | 18 | 0.700 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2019 | 52 | 0.680 |
Why?
|
Public Facilities | 1 | 2018 | 34 | 0.660 |
Why?
|
Metformin | 2 | 2015 | 835 | 0.650 |
Why?
|
Security Measures | 1 | 2018 | 77 | 0.640 |
Why?
|
Carcinoma | 2 | 2023 | 2375 | 0.630 |
Why?
|
Radiation-Protective Agents | 1 | 2015 | 90 | 0.530 |
Why?
|
Documentation | 1 | 2018 | 871 | 0.420 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1524 | 0.380 |
Why?
|
Pyrroles | 1 | 2015 | 1146 | 0.340 |
Why?
|
Radiotherapy | 1 | 2015 | 1533 | 0.330 |
Why?
|
Indoles | 1 | 2015 | 1839 | 0.300 |
Why?
|
Hematopoiesis | 1 | 2016 | 2072 | 0.280 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2019 | 297 | 0.280 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6364 | 0.260 |
Why?
|
Thyroid Nodule | 2 | 2023 | 750 | 0.260 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2529 | 0.230 |
Why?
|
Glucose | 1 | 2015 | 4397 | 0.220 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.180 |
Why?
|
Thyroxine | 2 | 2022 | 667 | 0.170 |
Why?
|
Nelfinavir | 1 | 2017 | 68 | 0.150 |
Why?
|
Hypothyroidism | 1 | 2022 | 658 | 0.140 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13695 | 0.140 |
Why?
|
Erythrocyte Count | 1 | 2015 | 163 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2043 | 0.130 |
Why?
|
Leukopenia | 1 | 2015 | 212 | 0.130 |
Why?
|
Thyrotropin | 1 | 2019 | 849 | 0.130 |
Why?
|
Blood Platelets | 2 | 2016 | 2508 | 0.130 |
Why?
|
Deoxyglucose | 1 | 2015 | 337 | 0.130 |
Why?
|
Adenoma, Oxyphilic | 1 | 2015 | 143 | 0.120 |
Why?
|
Prognosis | 3 | 2023 | 29063 | 0.120 |
Why?
|
Culture Media | 1 | 2015 | 908 | 0.110 |
Why?
|
Thyroid Hormones | 1 | 2015 | 390 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 730 | 0.110 |
Why?
|
Nausea | 1 | 2015 | 673 | 0.110 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16689 | 0.110 |
Why?
|
Caspases | 1 | 2015 | 928 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 611 | 0.100 |
Why?
|
DNA Damage | 2 | 2019 | 2432 | 0.100 |
Why?
|
Leukocyte Count | 1 | 2015 | 1588 | 0.100 |
Why?
|
Retrospective Studies | 8 | 2023 | 77449 | 0.100 |
Why?
|
Glycolysis | 1 | 2015 | 827 | 0.100 |
Why?
|
Heat-Shock Proteins | 1 | 2015 | 822 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 8428 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13102 | 0.100 |
Why?
|
Drug Synergism | 1 | 2015 | 1792 | 0.100 |
Why?
|
Thyroidectomy | 1 | 2015 | 879 | 0.090 |
Why?
|
Hemoglobins | 1 | 2015 | 1534 | 0.090 |
Why?
|
Endoplasmic Reticulum | 1 | 2015 | 1144 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2015 | 3701 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6895 | 0.080 |
Why?
|
Cell Survival | 1 | 2019 | 5882 | 0.080 |
Why?
|
Diarrhea | 1 | 2015 | 1348 | 0.080 |
Why?
|
Fatigue | 1 | 2015 | 1531 | 0.080 |
Why?
|
Bone Marrow Cells | 1 | 2015 | 2513 | 0.080 |
Why?
|
Cell Division | 1 | 2015 | 4568 | 0.080 |
Why?
|
Leukocytes | 1 | 2016 | 2043 | 0.080 |
Why?
|
Biopsy, Fine-Needle | 2 | 2023 | 1094 | 0.080 |
Why?
|
Humans | 15 | 2023 | 744343 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1990 | 0.070 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3479 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2019 | 10481 | 0.070 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57776 | 0.060 |
Why?
|
Phosphorylation | 1 | 2015 | 8436 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9438 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 2872 | 0.060 |
Why?
|
Aged | 6 | 2021 | 163280 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3703 | 0.050 |
Why?
|
Apoptosis | 2 | 2017 | 9727 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 5021 | 0.050 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.050 |
Why?
|
Adult | 6 | 2021 | 214055 | 0.050 |
Why?
|
Thyroid Function Tests | 1 | 2022 | 286 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6234 | 0.050 |
Why?
|
Ultrasonography | 2 | 2023 | 5985 | 0.040 |
Why?
|
Male | 7 | 2022 | 350118 | 0.040 |
Why?
|
Mutation | 1 | 2023 | 29786 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7880 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19905 | 0.040 |
Why?
|
Female | 6 | 2021 | 380194 | 0.040 |
Why?
|
Thyroglobulin | 1 | 2016 | 114 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2016 | 280 | 0.030 |
Why?
|
HIV Protease Inhibitors | 1 | 2017 | 430 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 625 | 0.030 |
Why?
|
Young Adult | 1 | 2016 | 56430 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3597 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2503 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2016 | 2016 | 0.020 |
Why?
|
Child | 1 | 2016 | 77709 | 0.020 |
Why?
|
Adolescent | 1 | 2016 | 85781 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2645 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4445 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4851 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3462 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5217 | 0.020 |
Why?
|
Pilot Projects | 1 | 2016 | 8324 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13284 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53288 | 0.010 |
Why?
|
Concepts
(104)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_